(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-((((lr,3S)-3-(2-(5-(tert-butyl)-lH-benzo[d]imidazol2yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4-diol
Title | Journal |
---|---|
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. | Blood 20130808 |
The pathogenesis of mixed-lineage leukemia. | Annual review of pathology 20120101 |
MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. | Cancer cell 20110712 |